Vaccine development is a long process that involves many steps in vitro and in vivo (preclinical, in laboratories) and in human volunteers and patients (clinical, in hospitals).
Started a project with a lead vaccine, or with a technology that could be used to develop a candidate vaccine can require many competencies. As access to such ressources can be limiting, many projects are on hold or cancelled. As the pandemic of COVID-19 is not over, and more outbreaks like SARS-CoV-2 could happen in the future, it is urgent to facilitate access to external ressources.
This is why Labtoo developed a tailor-made service to support Labs, Biotechs, Medtech, and Pharma companies in their SARS-CoV-2 vaccine research programs.
Labtoo offers many types of SARS-CoV-2 experimental services, for the development of new vaccine therapeutics. We work with a large international network of laboratories and service companies to provide the largest options for your project.
